Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Buy
1,037
+2
+0.2% +$453 0.01% 663
2026
Q1
$175K Buy
1,035
+3
+0.3% +$523 ﹤0.01% 669
2025
Q4
$168K Buy
1,032
+3
+0.3% +$451 ﹤0.01% 652
2025
Q3
$139K Sell
1,029
-82
-7% -$11.6K ﹤0.01% 659
2025
Q2
$144K Hold
1,111
– – ﹤0.01% 593
2025
Q1
$134K Buy
+1,111
New +$143K 0.01% 581
2023
Q1
– Sell
-300
Closed -$40K – 1044
2022
Q4
$40K Hold
300
– – ﹤0.01% 658
2022
Q3
$32K Hold
300
– – ﹤0.01% 645
2022
Q2
$31K Hold
300
– – ﹤0.01% 641
2022
Q1
$45K Hold
300
– – ﹤0.01% 567
2021
Q4
$34K Buy
+300
New +$32.8K ﹤0.01% 628

Other funds holding NUE

Capital Analysts LLC's NUE Position: Q2 2026 in Review

Capital Analysts LLC increased its Nucor (NUE) stake by 0.19% in Q2 2026, buying an estimated $453 and bringing the position to 1,037 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #663.

Capital Analysts LLC first reported a position in NUE in Q4 2021 and has held it in 11 quarters since. 1,549 funds tracked by Wall St. Rank hold NUE as of Q2 2026.

  • Capital Analysts LLC held 1,037 shares of Nucor worth $231K as of Q2 2026.
  • Capital Analysts LLC bought 2 Nucor shares in Q2 2026, an estimated $453.
  • Nucor made up 0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #663 holding.
  • Capital Analysts LLC first reported a position in Nucor in Q4 2021 and has held it in 11 quarters since.
  • 1,549 funds tracked by Wall St. Rank held Nucor as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.